Table of Contents Author Guidelines Submit a Manuscript
International Journal of Differential Equations
Volume 2018, Article ID 6710575, 13 pages
https://doi.org/10.1155/2018/6710575
Research Article

Mathematical Modeling of the Adaptive Immune Responses in the Early Stage of the HBV Infection

1Department of Mathematics, Faculty of Sciences and Technologies, Hassan II Mohammedia University, Mohammedia, Morocco
2Department of Mathematical Sciences, United Arab Emirates University, P.O. Box 15551, Al Ain, UAE

Correspondence should be addressed to Abdessamad Tridane; ea.ca.ueau@enadirt-a

Received 29 August 2017; Revised 18 November 2017; Accepted 18 December 2017; Published 1 February 2018

Academic Editor: Ahmed M. Elaiw

Copyright © 2018 Karam Allali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Ferrari, “HBV and the immune response,” Liver International, vol. 35, supplement 1, pp. 121–128, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Ferrari, A. Penna, A. Bertoletti et al., “Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection,” The Journal of Immunology, vol. 145, no. 10, pp. 3442–3449, 1990. View at Google Scholar · View at Scopus
  3. B. Rehermann and M. Nascimbeni, “Immunology of hepatitis B virus and hepatitis C virus infection,” Nature Reviews Immunology, vol. 5, no. 3, pp. 215–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Waters, M. Pignatelli, S. Galpin, K. Ishihara, and H. C. Thomas, “Virus-neutralizing antibodies to hepatitis B virus: The nature of an immunogenic epitope on the S gene peptide,” Journal of General Virology, vol. 67, no. 11, pp. 2467–2473, 1986. View at Publisher · View at Google Scholar · View at Scopus
  5. G. J. M. Webster, S. Reignat, M. K. Maini et al., “Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms,” Hepatology, vol. 32, no. 5, pp. 1117–1124, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Loggi, N. Gamal, F. Bihl, M. Bernardi, and P. Andreone, “Adaptive response in hepatitis B virus infection,” Journal of Viral Hepatitis, vol. 21, no. 5, pp. 305–313, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. D. R. Milich, M. Chen, F. Schödel, D. L. Peterson, J. E. Jones, and J. L. Hughes, “Role of B cells in antigen presentation of the hepatitis B core,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 94, no. 26, pp. 14648–14653, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Hagiwara, N. Nishida, and M. Kudo, “Antiviral therapy for chronic hepatitis B: Combination of nucleoside analogs and interferon,” World Journal of Hepatology, vol. 7, no. 23, pp. 2427–2431, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. R.-N. Chien, C.-H. Lin, and Y.-F. Liaw, “The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B,” Journal of Hepatology, vol. 38, no. 3, pp. 322–327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. L. J. Sun, J. W. Yu, Y. H. Zhao, P. Kang, and S. C. Li, “Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure,” Journal of Gastroenterology and Hepatology, vol. 25, no. 3, pp. 583–590, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Eikenberry, S. Hews, J. D. Nagy, and Y. Kuang, “The dynamics of a delay model of hepatitis B virus infection with logistic hepatocyte growth,” Mathematical Biosciences and Engineering, vol. 6, no. 2, pp. 283–299, 2009. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  12. S. A. Gourley, Y. Kuang, and J. D. Nagy, “Dynamics of a delay differential equation model of hepatitis B virus infection,” Journal of Biological Dynamics, vol. 2, no. 2, pp. 140–153, 2008. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  13. S. Hews, S. Eikenberry, J. D. Nagy, and Y. Kuang, “Rich dynamics of a hepatitis B viral infection model with logistic hepatocyte growth,” Journal of Mathematical Biology, vol. 60, no. 4, pp. 573–590, 2010. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  14. M. A. Nowak, S. Bonhoeffer, A. M. Hill, R. Boehme, H. C. Thomas, and H. Mcdade, “Viral dynamics in hepatitis B virus infection,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 93, no. 9, pp. 4398–4402, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Pang and J.-A. Cui, “Analysis of a hepatitis B viral infection model with immune response delay,” International Journal of Biomathematics, vol. 10, no. 2, Article ID 1750020, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Tridane, K. Hattaf, R. Yafia, and F. A. Rihan, “Mathematical modeling of hbv with the antiviral therapy for the immunocompromised patients,” Communications in Mathematical Biology and Neuroscience, vol. 2016, 31 pages, 2016. View at Google Scholar
  17. Y. Wang and X. Liu, “Dynamical behaviors of a delayed HBV infection model with logistic hepatocyte growth, cure rate and CTL immune response,” Japan Journal of Industrial and Applied Mathematics, vol. 32, no. 3, pp. 575–593, 2015. View at Publisher · View at Google Scholar · View at MathSciNet
  18. N. Yousfi, K. Hattaf, and A. Tridane, “Modeling the adaptive immune response in {HBV} infection,” Journal of Mathematical Biology, vol. 63, no. 5, pp. 933–957, 2011. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  19. A. Meskaf, K. Allali, and Y. Tabit, “Optimal control of a delayed hepatitis B viral infection model with cytotoxic T-lymphocyte and antibody responses,” International Journal of Dynamics and Control, vol. 5, no. 3, pp. 893–902, 2017. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  20. J. E. Forde, S. M. Ciupe, A. Cintron-Arias, and S. Lenhart, “Optimal control of drug therapy in a hepatitis B model,” Applied Sciences (Switzerland), vol. 6, no. 8, article no. 219, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Elaiw, M. A. Alghamdi, and S. Aly, “Hepatitis B virus dynamics: Modeling, analysis, and optimal treatment scheduling,” Discrete Dynamics in Nature and Society, vol. 2013, Article ID 712829, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Tchinda Mouofo, J. J. Tewa, B. Mewoli, and S. Bowong, “Optimal control of a delayed system subject to mixed control-state constraints with application to a within-host model of hepatitis virus B,” Annual Reviews in Control, vol. 37, no. 2, pp. 246–259, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. M. Ciupe, R. M. Ribeiro, P. W. Nelson, G. Dusheiko, and A. S. Perelson, “The role of cells refractory to productive infection in acute hepatitis B viral dynamics,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 104, no. 12, pp. 5050–5055, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. G. K. Michalopoulos and M. C. DeFrances, “Liver regeneration,” Science, vol. 276, no. 5309, pp. 60–65, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Nowak and R. M. May, Virus Dynamics, Oxford University Press, London, UK, 2000. View at MathSciNet
  26. S. A. Whalley, J. M. Murray, D. Brown et al., “Kinetics of acute hepatitis B virus infection in humans,” The Journal of Experimental Medicine, vol. 193, no. 7, pp. 847–853, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. M.-P. Bralet, S. Branchereau, C. Brechot, and N. Ferry, “Cell lineage study in the liver using retroviral mediated gene transfer: Evidence against the streaming of hepatocytes in normal liver,” The American Journal of Pathology, vol. 144, no. 5, pp. 896–905, 1994. View at Google Scholar · View at Scopus
  28. R. A. Macdonald, ““Lifespan” of Liver Cells: Autoradiographic Study Using Tritiated Thymidine in Normal, Cirrhotic, and Partially Hepatectomized Rats,” JAMA Internal Medicine, vol. 107, no. 3, pp. 335–343, 1961. View at Publisher · View at Google Scholar · View at Scopus
  29. S. M. Ciupe, R. M. Ribeiro, P. W. Nelson, and A. S. Perelson, “Modeling the mechanisms of acute hepatitis B virus infection,” Journal of Theoretical Biology, vol. 247, no. 1, pp. 23–35, 2007. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  30. M. A. Nowak and R. M. May, Virus Dynamics: Mathematics Principles of Immunology and Virology, Oxford University Press, London, UK, 2000. View at MathSciNet
  31. S. M. Ciupe, R. M. Ribeiro, and A. S. Perelson, “Antibody responses during hepatitis B viral infection,” PLoS Computational Biology, vol. 10, no. 7, Article ID e1003730, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Ahmed and D. Gray, “Immunological memory and protective immunity: Understanding their relation,” Science, vol. 272, no. 5258, pp. 54–60, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. W. H. Fleming and R. W. Rishel, Deterministic and Stochastic Optimal Control, vol. 1, Springer, New York, NY, USA, 1975. View at MathSciNet
  34. D. L. Lukes, Differential Equations: Classical to Controlled, Mathematics in Science and Engineering, Academic Press, New York, NY. USA, 1982. View at MathSciNet
  35. L. Gollmann, D. Kern, and H. Maurer, “Optimal control problems with delays in state and control variables subject to mixed control-state constraints,” Optimal Control Applications and Methods, vol. 30, no. 4, pp. 341–365, 2009. View at Publisher · View at Google Scholar · View at MathSciNet
  36. A. B. Gumel, P. N. Shivakumar, and B. M. Sahai, “A mathematical model for the dynamics of HIV-1 during the typical course of infection,” Nonlinear Analysis: Theory, Methods & Applications, vol. 47, no. 3, pp. 1773–1783, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Karrakchou, M. Rachik, and S. Gourari, “Optimal control and infectiology: application to an HIV/AIDS model,” Applied Mathematics and Computation, vol. 177, no. 2, pp. 807–818, 2006. View at Publisher · View at Google Scholar · View at MathSciNet
  38. L. Chen, K. Hattaf, and J. Sun, “Optimal control of a delayed SLBS computer virus model,” Physica A: Statistical Mechanics and its Applications, vol. 427, pp. 244–250, 2015. View at Publisher · View at Google Scholar · View at MathSciNet
  39. K. Hattaf and N. Yousfi, “Optimal control of a delayed HIV infection model with immune response using an efficient numerical method,” ISRN biomathematics, vol. 2012, Article ID 215124, 7 pages, 2012. View at Publisher · View at Google Scholar
  40. H. Laarabi, A. Abta, and K. Hattaf, “Optimal Control of a Delayed SIRS Epidemic Model with Vaccination and Treatment,” Acta Biotheoretica, vol. 63, no. 2, pp. 87–97, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Boglione, G. Cariti, G. Di Perri, and A. D'Avolio, “Sequential therapy with entecavir and pegylated interferon in a cohort of young patients affected by chronic hepatitis B,” Journal of Medical Virology, vol. 88, no. 11, pp. 1953–1959, 2016. View at Publisher · View at Google Scholar · View at Scopus